Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 07 Jun 2023 for Jazz Pharmaceuticals plc, €252k. Read the official filing
Filing timeline
BuySaleKim Sablich
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kim Sablich: trading record in brief
This profile gathers the share dealings of Kim Sablich across 2 companies, led by Jazz Pharmaceuticals plc and Eiger BioPharmaceuticals, Inc. In total, 8 filings cover trades dated from 5 June 2021 to 5 June 2023.
Every open-market trade on record is a sale: 2 sales worth €555k. Besides market trades, the filings include 5 share grants. In 2023 alone, the filings show no purchases and 1 sale.
The record was last updated on 7 June 2023 with a transaction (€252k) in Jazz Pharmaceuticals plc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kim Sablich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
2,082 shares@ US$129.7314.0% of flowOrdinary SharesSEC:0001765581-23-000046:0
1,752 shares@ US$139.4212.9% of flowOrdinary SharesSEC:0001765581-23-000036:0
10,429 shares0Ordinary SharesSEC:0001765581-23-000017:0
1,759 shares@ US$149.250.0017% mcap18.7% of flowOrdinary SharesSEC:0001765581-22-000057:0
6,000 shares0Common StockSEC:0001140361-22-009263:0
9,953 shares0Ordinary SharesSEC:0001765581-22-000028:0
2,748 shares@ US$135.007425.6% of flowOrdinary SharesSEC:0001765581-21-000125:0
1,452 shares@ US$176.4716.7% of flowOrdinary SharesSEC:0001765581-21-000061:0
8 of 8 declarations
